Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 24, 2015
- Accepted in final form May 8, 2015
- First Published June 24, 2015.
Article Versions
- Previous version (June 24, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Kumar B. Rajan, PhD,
- Robert S. Wilson, PhD,
- Jennifer Weuve, MPH, ScD,
- Lisa L. Barnes, PhD and
- Denis A. Evans, MD
- Kumar B. Rajan, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
Associate Professor, Rush University Medical Center
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert S. Wilson, PhD,
NONE
NONE
NONE
(1) Aging, Neuropsychology, and Cognition, Consulting Editor, 2004-present; (2) Psychology and Aging, Consulting Editor, 2007-present; (3) Neuropsychology, Consulting Editor, 2014-present.
NONE
NONE
NONE
(1) Pain Therapeutics, Inc.
NONE
NONE
NONE
NONE
(1) NIH/NIA R01AG17917, Co-I, 2001-2014; (2) NIH/NIA P30AG10161, Co-I, 1991-2014; (3) NIH/NIA R01AG34374, Co-I, 2008-2014; (4) NIH/NIA R01AG15819, Co-I, 1998-2014.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jennifer Weuve, MPH, ScD,
NONE
NONE
(1) Health Effects Institute, a non-profit entity [speaker honorarium]
NONE
NONE
NONE
NONE
(1) Fidelity Biosciences (2) Alzheimer's Drug Discovery Foundation (2) Alzheimer's Association
NONE
NONE
NONE
NONE
(1) NIH-NIEHS/R21ES019712, co-investigator, 2010-2013 (2) NIH-NIEHS/R21ES020404, PI, 2012-2015
NONE
(1) Alzheimer's Association NIRG-12-242395, PI, 2012-2014
(1) Exxon Mobile (stocks)
NONE
NONE
NONE
NONE
NONE
- Lisa L. Barnes, PhD and
NONE
NONE
NONE
Journal of Aging And Health, member of editorial board, 2006 - present. No compensation received.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1)NIA, P30-10161, PI of Clinical Core, 9/30/91 ? 6/30/16 (2)NIA, R01-22018, PI, 8/01/2010-7/31/2015 (3)NIMHD,P20-6886, PI 6/15/2012 - 2/1/2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Denis A. Evans, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Principal Investigator or Co-Investigator) of NIH grants AG11101, AG036650, AG030146, AG10161, AG021972, ES10902, NR009543, HL084209, and AG12505l
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Internal Medicine, Rush Institute for Healthy Aging (K.B.R., J.W., D.A.E.), Rush Alzheimer Disease Center (R.S.W., L.L.B.), and Departments of Neurological Sciences (R.S.W., L.L.B.) and Behavioral Sciences (R.S.W., L.L.B.), Rush University Medical Center, Chicago, IL.
- Correspondence to Dr. Rajan: kumar_rajan{at}rush.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Contribution of Alzheimer disease to mortality in the United StatesBryan D. James, Sue E. Leurgans, Liesi E. Hebert et al.Neurology, March 05, 2014 -
Articles
Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adultsB.C. Dickerson, T.R. Stoub, R.C. Shah et al.Neurology, April 13, 2011 -
Article
Temporal changes in the likelihood of dementia and MCI over 18 years in a population sampleKumar B. Rajan, Jennifer Weuve, Robert S. Wilson et al.Neurology, December 05, 2019 -
Articles
Amnestic syndrome of the medial temporal type identifies prodromal ADA longitudinal studyM. Sarazin, C. Berr, J. De Rotrou et al.Neurology, November 05, 2007